1. Adler CH, Zimmerman RS, Lyons MK, Simeone F, Brin MF. Perioperative use of botulinum toxin for movement disorder-induced cervical spine disease. Mov Disord. 1996; 11:79–81. PMID:
8771071.
Article
2. Aguirregomozcorta M, Pagonabarraga J, Diaz-Manera J, Pascual-Sedano B, Gironell A, Kulisevsky J. Efficacy of botulinum toxin in severe Tourette syndrome with dystonic tics involving the neck. Parkinsonism Relat Disord. 2008; 14:443–445. PMID:
18337152.
Article
3. Bloch MH, Leckman JF. Clinical course of Tourette syndrome. J Psychosom Res. 2009; 67:497–501. PMID:
19913654.
Article
4. Dobbs M, Berger JR. Cervical myelopathy secondary to violent tics of Tourette's syndrome. Neurology. 2003; 60:1862–1863. PMID:
12796554.
Article
5. Eddy CM, Rickards HE, Cavanna AE. Treatment strategies for tics in Tourette syndrome. Ther Adv Neurol Disorder. 2011; 4:25–45.
Article
6. Isaacs JD, Adams M, Lees AJ. Noncompressive myelopathy associated with violent axial tics of Tourette syndrome. Neurology. 2010; 74:697–698. PMID:
20177125.
Article
7. Ko DY, Kim SK, Chae JH, Wang KC, Phi JH. Cervical spondylotic myelopathy caused by violent motor tics in a child with Tourette syndrome. Childs Nerv Syst. 2013; 29:317–321. PMID:
23053364.
Article
8. Krauss JK, Jankovic J. Severe motor tics causing cervical myelopathy in Tourette's syndrome. Mov Disord. 1996; 11:563–566. PMID:
8866498.
Article
9. Lin JJ, Wang HS, Wong MC, Wu CT, Lin KL. Tourette's syndrome with cervical disc herniation. Brain Dev. 2007; 29:61–63. PMID:
17188440.
Article
10. Muroi A, Matsumura A, Asakawa H, Enomoto T, Iwasaki N, Nose T. Myelopathy caused by tics in an adolescent, associated with T2 signal intensity changes of the spinal cord. Childs Nerv Syst. 2002; 18:191–194. PMID:
11981634.
Article